• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·US·Healthcare·LIFD
Share

LFTD Partners Inc. Stocks

$ 0.2Last Updated 29.07.2026

Issuer Rating

2/7
Performance

Modest

Risk

High

Recommendation

Sell

Market Cap

$ 2.96M

$ 0.2
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

LFTD Partners Inc., operating through its subsidiary Lifted Made, specializes in the production and distribution of two distinct product lines. The first consists of psychedelic products, marketed under their Silly Shruum brand. The second encompasses hemp-derived cannabinoid products, which they sell under the Urb Finest Flowers label. Established in 1986, the company was previously known as Acquired Sales Corp. before officially rebranding to LFTD Partners Inc. in September 2021. Its corporate headquarters are located in Jacksonville, Florida.

Company Valuation

Fairly valued
4/7

Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is reasonably priced on P/FCF.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

31.07.2026 20:36

Nvidia Finds Itself in the Unfamiliar Role of an Undervalued Growth Stock — Morningstar

31.07.2026 19:29

"There's no end in sight to the rise in capital expenditures": The four Big Tech companies' investments in AI have already exceeded $1 trillion

31.07.2026 18:43

Profits at the two leading U.S. oil companies have skyrocketed. They've found a "weak spot."

31.07.2026 18:37

Novo Nordisk shares plummeted 10% after a heart drug trial failed

31.07.2026 18:00

The U.S. dollar is poised for its worst week in three months

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026